Telemedical technologies in urological cancer care: past, present and future applications

Etai M Bogen Norwegian Centre for Telemedicine and Integrated Care, Tromsø, Norway; Department of Urology, University Hospital of Northern Norway, Tromsø, Norway; Department of Gastrointestinal surgery, University Hospital of Northern Norway, Tromsø, Norway; Virtual Surgical Skills and Simulation Centre, Institute of Cancer, Queen Mary University of London, London, UK

Erling Aarsæther Department of Urology, University Hospital of Northern Norway, Tromsø, Norway; Norwegian Centre for Telemedicine and Integrated Care, Tromsø, Norway

Knut M Augestad Norwegian Centre for Telemedicine and Integrated Care, Tromsø, Norway; Department of Gastrointestinal surgery, University Hospital of Northern Norway, Tromsø, Norway

Rolv-Ole Lindsetmo Norwegian Centre for Telemedicine and Integrated Care, Tromsø, Norway; Department of Gastrointestinal surgery, University Hospital of Northern Norway, Tromsø, Norway

Hiten RH Patel Norwegian Centre for Telemedicine and Integrated Care, Tromsø, Norway. [email protected]; Department of Urology, University Hospital of Northern Norway, Tromsø, Norway; Department of Gastrointestinal surgery, University Hospital of Northern Norway, Tromsø, Norway; Virtual Surgical Skills and Simulation Centre, Institute of Cancer, Queen Mary University of London, London, UK

Abstract

Since the initial development of telegraphy by Sir Charles Wheatstone in 1837 and the telephone by Alexander Graham Bell in 1875, doctors have been able to convey medical information across great distances. The exchange and sharing of medical information has evolved and adapted to suit the vast array of today’s medicine. Early adopters of telemedicine within clinical practice have gained significant health economic benefits. The arrival of wireless connections has further enhanced the possibilities for all clinical work with focus on diagnosis, treatment and management of urological cancers, as highlighted in this article.

Keywords::

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Telemedical technologies in urological cancer care: past, present and future applications

Information for

Open access

Opportunities

Help and information

Telemedical technologies in urological cancer care: past, present and future applications

Abstract

Financial & competing interests disclosure

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature